Nanobiotix S.A. (NBTX) NASDAQ

21.84

+0.8105(+3.85%)

Updated at December 04 03:29PM

Currency In USD

Valuation

Market Cap131M
Enterprise Value132.16M
P/E Ratio-12.83
PEG Ratio0.15
Price/Sales Ratio-76.84
Price/Book Ratio-13.31
Enterprise/Revenue-76.94
Enterprise/EBITDA-13.2

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin5.87
Operating Margin5.89

Management Effectiveness

Return On Assets-1.01
Return On Equity1.56

Income Statement

Revenue-11.61M
Revenue/Share-0.25
Gross Profit-11.61M
EBITDA-58.32M
Net Income-68.13M
Diluted EPS-1.44

Balance Sheet

Total Cash28.82M
Total Cash/Share1.05
Total Debt51.24M
Total Debt/Equity-0.77
Current Ratio1.04
Book Value Per Share-1.39

Price History

52-Week Change639.1
52-Week High30.35
52-Week Low2.76
Moving Average 50 Days21.19
Moving Average 200 Days9.29

Statistics

Average Volume99,380
Shares Outstanding47.47M
% Held by Institutions11.9

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A